About Pharma Serv Ventures Private Limited
Data last updated: 06 January 2026
Pharma Serv Ventures Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in business and IT consulting, a part of the broader business process outsourcing sector. Incorporated on 29 May 2007, the company has been in operation for over 19 years.
Registered with ROC Mumbai under CIN U24233MH2007PTC171203.
Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10.34 Lakh. Formerly known as Enaltec Pharma Private Limited. It is led by directors including Sameer Ashok Paigankar and Darshak Jitendra Shah.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Unit Number 110 First Floor Kanakia Zillion Lbs Road Bkc Annexure Kurla (West) Mumbai, 400070, Maharashtra, India – 400070.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.96 Lakh, a decline of 4% compared to the previous year.
The company is associated with 1 brand - Pharmaserv. As per MCA filings, the company has open charges of ₹1.8 Cr and satisfied charges of ₹1.8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaserv.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressUnit Number 110 First Floor Kanakia Zillion Lbs Road Bkc Annexure Kurla (West) Mumbai, 400070, Maharashtra, India – 400070
-
IndustryBusiness Outsourcing, Business & IT Consulting
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Pharma Serv Ventures Private Limited
Pharma Serv Ventures Private Limited operates one associated brand: PharmaServ. These brands represent Pharma Serv Ventures Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Business management consulting services are provided to pharmaceutical firms. | pharmaserv.in |
Competitors & Alternatives of Pharma Serv Ventures Private Limited
Brands and companies operating in the same space as Pharma Serv Ventures Private Limited include Booz Allen Hamilton, Cyient, ZS and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Booz Allen Hamilton
|
Analytics, cybersecurity, and digital transformation services are provided. | Mclean, United States, United States | 1914 |
Cyient
|
Provider of digital engineering and technology services | Hyderabad, India, India | 1991 |
ZS
|
Strategic and management consulting services are provided worldwide. | Evanston, United States, United States | 1983 |
Teneo
|
Business consulting, financial advisory, and crisis management services are provided. | New York, United States, United States | 2011 |
Prophet
|
Brand and marketing consulting solutions provider | San Francisco, United States, United States | 1992 |
Huron Consulting Group
|
Advisory, consulting, technology, and analytics solutions are provided across industries. | Amman, Jordan, Jordan | 2002 |
Visiativ
|
Software integration and digital transformation services are provided. | Lyon, France, France | 1987 |
Business Activity of Pharma Serv Ventures Private Limited
Pharma Serv Ventures Private Limited is engaged in the principal business activity of accommodation and food service, with detailed activities including accommodation services provided by hotel, inns, resorts, holiday homes, hostel, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| I | Accommodation and Food Service | I1 | Accommodation services provided by Hotel, Inns, Resorts, holiday homes, hostel, etc. | ********* |
Auditor Details of Pharma Serv Ventures Private Limited
Pharma Serv Ventures Private Limited is audited by PHD & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PHD & Associates | blur-value | blur-value | blur-value |
Board of Directors of Pharma Serv Ventures Private Limited
Pharma Serv Ventures Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sameer Ashok Paigankar
Also directs:
Pharma-Serv Healthcare Private Limited, Lavue Pharmaceuticals Private Limited, Nutragenix Healthcare Private Limited and 4 more
|
Director | 29 May 2007 | 19 Years 1 Months | Current |
| Darshak Jitendra Shah | Director | 29 May 2007 | 19 Years 1 Months | Current |
| Murali Venkata Krishna Sistla | Director | 07 Nov 2008 | 17 Years 8 Months | Current |
Financials of Pharma Serv Ventures Private Limited FY 2025 filings available
Pharma Serv Ventures Private Limited reported revenue of ₹66.96 Lakh (down 4% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Pharma Serv Ventures Private Limited
As of FY 2023, Pharma Serv Ventures Private Limited's shareholding pattern shows 99.61% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Pharma Serv Ventures Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2019 | Hdfc Bank Limited | ₹1.8 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Pharma Serv Ventures Private Limited
View historical data on people associated with Pharma Serv Ventures Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Pharma Serv Ventures Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Pharma Serv Ventures Private Limited
GSTIN & GST Filing Data of Pharma Serv Ventures Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Pharma Serv Ventures Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Pharma Serv Ventures Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Pharma Serv Ventures Private Limited
MSME Payment Delays by Pharma Serv Ventures Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Pharma Serv Ventures Private Limited
Subsidiaries & Group Companies of Pharma Serv Ventures Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Pharma Serv Ventures Private Limited with ownership details.
MCA Filings & Documents of Pharma Serv Ventures Private Limited
MCA Filings & Documents of Pharma Serv Ventures Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Pharma Serv Ventures Private Limited
Frequently Asked Questions about Pharma Serv Ventures Private Limited
Pharma Serv Ventures Private Limited is an active private limited company in the business outsourcing sector based in Mumbai, Maharashtra, India. It was incorporated on 29 May 2007 (19+ years old) and is registered under CIN U24233MH2007PTC171203.
Pharma Serv Ventures Private Limited reported revenue of ₹66.96 Lakh for FY 2025 (down 4.00% YoY).
The current directors of Pharma Serv Ventures Private Limited are:
The primary industry of Pharma Serv Ventures Private Limited is business outsourcing. The company specifically operates in business and IT consulting. The company is currently active in this sector.
Pharma Serv Ventures Private Limited can be reached at the registered office: Unit Number 110 First Floor Kanakia Zillion Lbs Road Bkc Annexure Kurla West Mumbai, 400070, Maharashtra, India – 400070, or through the website pharmaserv.in.
The authorised capital is ₹50 Lakh, and the paid-up capital is ₹10.34 Lakh.